| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
447,536
|
523,335
|
504,063
|
579,140
| | Cost of Revenue | 307,413 | 359,835 | 332,266 | 382,395 | | |
Gross Profit
|
140,123
|
163,500
|
171,797
|
196,745
| |
|
Operating Expenses |
|
Research Development | 44,208 | 44,358 | 43,299 | 46,640 |
|
Selling General and Administrative | 81,811 | 89,514 | 75,656 | 84,297 |
|
Non Recurring | 1,013 | (1,790) | (5,054) | 7,720 |
|
Others | 10,744 | 11,943 | 11,929 | 12,025 |
|
|
|
Total Operating Expenses | 137,776 | 144,025 | 125,830 | 150,682 | | | |
Operating Income or Loss
|
2,347
|
19,475
|
45,967
|
46,063
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 244 | (1,235) | (972) | (602) |
|
Earnings Before Interest And Taxes | 2,591 | 18,240 | 44,995 | 45,461 |
|
Interest Expense | 2,338 | 2,521 | 2,551 | 2,606 |
|
Income Before Tax | 253 | 15,719 | 42,444 | 42,855 |
|
Income Tax Expense | (3,243) | (745) | 6,547 | 10,564 |
|
Minority Interest | (926) | (504) | (550) | (676) |
|
|
|
Net Income From Continuing Ops | 2,570 | 15,960 | 35,347 | 31,615 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
2,570
|
15,960
|
35,347
|
31,615
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
2,570
|
15,960
|
35,347
|
31,615
|
|